Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis

Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis

The gut microbiota is involved in the development of the immune system and can modulate the risk for immune-mediated disorders such as multiple sclerosis (MS). Dysbiosis has been demonstrated in MS patients and its restoration by disease-modifying treatments (DMTs) is hypothesized. We aimed to study...

Full description

Bibliographic Details
Main Authors: Caterina Ferri, Massimiliano Castellazzi, Nicola Merli, Michele Laudisi, Elisa Baldin, Eleonora Baldi, Leonardo Mancabelli, Marco Ventura, Maura Pugliatti
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
gut microbiota
multiple sclerosis
dimethyl fumarate
gastrointestinal side effects
flushing
<i>Clostridium</i>
Online Access:https://www.mdpi.com/1422-0067/24/3/2720

Similar Items

Similar Items